László Rejtő

780 total citations
33 papers, 376 citations indexed

About

László Rejtő is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, László Rejtő has authored 33 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in László Rejtő's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). László Rejtő is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). László Rejtő collaborates with scholars based in Hungary, Spain and United States. László Rejtő's co-authors include M. Udvardy, István Tornai, Domenica Gandini, E. Sally Ward, Nataliya Romanyuk, Blanca Sánchez‐González, Marie Godar, Adrian C. Newland, Katrien Verschueren and Howard A. Liebman and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

László Rejtő

31 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Rejtő Hungary 9 143 108 62 60 59 33 376
Dawn Swan Ireland 11 186 1.3× 79 0.7× 85 1.4× 20 0.3× 61 1.0× 43 377
Lindsay B. Kelmenson United States 7 75 0.5× 110 1.0× 42 0.7× 42 0.7× 115 1.9× 8 578
Robert M. Fox United States 12 157 1.1× 41 0.4× 83 1.3× 36 0.6× 36 0.6× 24 345
Huiying Qiu China 14 159 1.1× 119 1.1× 213 3.4× 36 0.6× 108 1.8× 91 534
Sean Lang Canada 9 291 2.0× 52 0.5× 49 0.8× 27 0.5× 84 1.4× 9 450
Ilenia Di Cola Italy 7 109 0.8× 86 0.8× 39 0.6× 25 0.4× 118 2.0× 24 397
Kazuho Shimura Japan 10 91 0.6× 59 0.5× 123 2.0× 71 1.2× 85 1.4× 34 328
Ewa Haładyj Poland 13 61 0.4× 68 0.6× 55 0.9× 49 0.8× 105 1.8× 39 414
D Logar Slovenia 13 53 0.4× 63 0.6× 52 0.8× 29 0.5× 85 1.4× 17 509
Xiaoying Sun China 12 64 0.4× 29 0.3× 56 0.9× 38 0.6× 71 1.2× 25 393

Countries citing papers authored by László Rejtő

Since Specialization
Citations

This map shows the geographic impact of László Rejtő's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Rejtő with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Rejtő more than expected).

Fields of papers citing papers by László Rejtő

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Rejtő. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Rejtő. The network helps show where László Rejtő may publish in the future.

Co-authorship network of co-authors of László Rejtő

This figure shows the co-authorship network connecting the top 25 collaborators of László Rejtő. A scholar is included among the top collaborators of László Rejtő based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Rejtő. László Rejtő is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marton, A., et al.. (2024). The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia. Pathology & Oncology Research. 30. 1611747–1611747. 1 indexed citations
4.
Szász, Róbert, et al.. (2020). Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia. Scientific Reports. 10(1). 16532–16532. 7 indexed citations
5.
Rejtő, László, et al.. (2019). A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots. Annals of Hematology. 98(6). 1413–1420. 10 indexed citations
6.
Newland, Adrian C., Blanca Sánchez‐González, László Rejtő, et al.. (2019). Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia. Blood. 134(Supplement_1). 895–895. 9 indexed citations
7.
Udvardy, M., Mária Papp, Jolán Hársfalvi, et al.. (2016). Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation. Transplantation Proceedings. 48(10). 3397–3405. 3 indexed citations
8.
Oláh, Éva, et al.. (2016). Strong Correlation between the Expression Levels of HDAC4 and SIRT6 in Hematological Malignancies of the Adults. Pathology & Oncology Research. 23(3). 493–504. 5 indexed citations
9.
Rejtő, László, Péter Batár, Zsófia Miltényi, et al.. (2016). Az akut myeloid leukaemia gyógyszeres kezelése. Jelenlegi lehetőségek, jövőbeli kilátások. Orvosi Hetilap. 157(22). 843–848. 1 indexed citations
10.
Buglyó, Gergely, et al.. (2015). WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors. Pathology & Oncology Research. 22(1). 217–221. 19 indexed citations
11.
Paholcsek, Melinda, József Kónya, László Rejtő, et al.. (2015). Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia. BMC Infectious Diseases. 15(1). 251–251. 11 indexed citations
12.
Antal‐Szalmás, Péter, et al.. (2012). Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay. Clinical Chemistry and Laboratory Medicine (CCLM). 50(4). 689–92. 5 indexed citations
13.
Tóth, Judit, János Kappelmayer, M. Udvardy, et al.. (2009). Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera. Platelets. 20(4). 282–287. 2 indexed citations
14.
Balázs, Margit, et al.. (2004). Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: A report of two siblings. Leukemia & lymphoma. 46(3). 421–423. 2 indexed citations
15.
Rejtő, László, et al.. (2004). [New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia].. PubMed. 145(35). 1795–800. 1 indexed citations
16.
Simon, Ágnes, et al.. (2003). [Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia].. PubMed. 144(31). 1531–5. 2 indexed citations
17.
Karászi, Éva, Katalin Jakab, László Homolya, et al.. (2001). Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. British Journal of Haematology. 112(2). 308–314. 66 indexed citations
19.
Boda, Z, et al.. (1996). Low Molecular Weight Heparin as Thromboprophylaxis in Familial Thrombophilia during the Whole Period of Pregnancy. Thrombosis and Haemostasis. 76(1). 128–128. 17 indexed citations
20.
Kiss, J., et al.. (1992). HTLV-related markers in a hungarian patient with adult T-cell leukemia. Leukemia Research. 16(11). 1125–1131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026